QRGenetics
QRGenetics uses GenAI to design targeted treatments for rare genetic diseases. Its proprietary platform uncovers disease mechanisms, identifies therapeutic targets, and guides drug discovery in collaboration with pharmaceutical partners. The company is clinical-stage and applies these methods to advance candidates toward human trials. It has reduced the development timeline from disease identification to human trials and contributed to over 20 successful cases. The approach aims to scale precision medicine for broader patient populations.
QRGenetics
QRGenetics uses GenAI to design targeted treatments for rare genetic diseases. Its proprietary platform uncovers disease mechanisms, identifies therapeutic targets, and guides drug discovery in collaboration with pharmaceutical partners. The company is clinical-stage and applies these methods to advance candidates toward human trials. It has reduced the development timeline from disease identification to human trials and contributed to over 20 successful cases. The approach aims to scale precision medicine for broader patient populations.